KPMA opens membership to foreign drug companies.

The KPMA decided in the executive meeting on March 24 that the eligibility for KPMA membership widely opened to the foreign multinational drug companies regardless of the manufacturing facility located in Korea if their parent companies had their production facilities or research laboratories in overseas countries.

This policy had been raised by former top executives, and recently assigned t...